Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Okroglic, Sandra ^a   Widmann, Catherine N ^a   Urbach, Horst ^a   Scheltens, Philip ^b   Heneka, Michael T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; APRAXIA; ARTICLE; BASAL GANGLION; CEREBRAL MICROANGIOPATHY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCONTINENCE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROANGIOPATHY; OBESITY; PARIETO-OCCIPITAL SULCUS; PROTEIN BLOOD LEVEL; RATING SCALE; RISK FACTOR; SEIZURE; SEX DIFFERENCE; SYMPTOM; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO; WAHLUND SCALE; WHITE MATTER LESION;

AGED; AGED, 80 AND OVER; AGING; CEREBRAL SMALL VESSEL DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873502079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053455     Document Type: Article

References (35)

1. Pantoni L, (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9: 689-701 doi:10.1016/S1474-4422(10)70104-6.
2. Pantoni L, Garcia JH, (1997) Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann N Y Acad Sci 826: 92-102.
3. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, et al. (2011) Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatr 82: 126-135 doi:10.1136/jnnp.2009.204685.
4. Patel B, Markus HS, (2011) Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 6: 47-59 doi:10.1111/j.1747-4949.2010.00552.x.
5. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, et al. (2008) Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70: 935-942 doi:10.1212/01.wnl.0000305959.46197.e6.
6. Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, et al. (2008) Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc 56: 1638-1643 doi:10.1111/j.1532-5415.2008.01832.x.
7. Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, et al. (2010) Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 40: 603-610 doi:10.1017/S0033291709990857.
8. Inzitari M, Pozzi C, Rinaldi LA, Masotti G, Marchionni N, et al. (2007) Cognitive and functional impairment in hypertensive brain microangiopathy. J Neurol Sci 257: 166-173 doi:10.1016/j.jns.2007.01.026.
9. Kuo H-K, Lipsitz LA, (2004) Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol A Biol Sci Med Sci 59: 818-826.
10. Marchesi VT, (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25: 5-13 doi:10.1096/fj.11-0102ufm.
11. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, et al. (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44: 1246-1252.
12. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, et al. (1987) Vascular risk factors and leuko-araiosis. Arch Neurol 44: 42-47.
13. Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser M-G, et al. (2005) Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112: 1644-1650 doi:10.1161/CIRCULATIONAHA.104.501163.
14. Mok VCT, Lam WWM, Fan YH, Wong A, Ng PW, et al. (2009) Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 256: 750-757 doi:10.1007/s00415-009-5008-7.
15. Stewart R, Liolitsa D, (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16: 93-112.
16. Jagust W, Harvey D, Mungas D, Haan M, (2005) Central obesity and the aging brain. Arch Neurol 62: 1545-1548 doi:10.1001/archneur.62.10.1545.
17. Laloux P, Galanti L, Jamart J, (2004) Lipids in ischemic stroke subtypes. Acta Neurol Belg 104: 13-19.
18. Reitz C, Berger K, de Maat MPM, Stoll M, Friedrichs F, et al. (2007) CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke 38: 2356-2359 doi:10.1161/STROKEAHA.107.482661.
19. Isenegger J, Meier N, Lämmle B, Alberio L, Fischer U, et al. (2010) D-dimers predict stroke subtype when assessed early. Cerebrovasc Dis 29: 82-86 doi:10.1159/000256652.
20. de Lau LML, van Meurs JBJ, Uitterlinden AG, Smith AD, Refsum H, et al. (2010) Genetic variation in homocysteine metabolism, cognition, and white matter lesions. Neurobiol Aging 31: 2020-2022 doi:10.1016/j.neurobiolaging.2008.10.004.
21. Brouns R, Van Den Bossche J, De Surgeloose D, Sheorajpanday R, De Deyn PP, (2009) Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke. J Neurol Sci 285: 185-190 doi:10.1016/j.jns.2009.06.032.
22. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, et al. (2002) Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 51: 285-289.
23. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, et al. (2005) C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112: 900-905 doi:10.1161/CIRCULATIONAHA.104.506337.
24. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, et al. (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32: 1318-1322.
25. SPSS Statistics (2008) Chicago, Illinois, USA: SPSS Inc. p. Available: http://www.spss.com/de/software/statistics/. Accessed 2011 Feb 18.
26. Oh S-H, Kim N-K, Kim S-H, Kim J-K, Kim H-S, et al. (2010) The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke. J Neurol Sci 293: 97-101 doi:10.1016/j.jns.2010.02.025.
27. Lin H-J, Yeh P-S, Tsai T-C, Cheng T-J, Ke D, et al. (2007) Differential risks of subsequent vascular events for transient ischaemic attack and minor ischaemic stroke. J Clin Neurosci 14: 17-21 doi:10.1016/j.jocn.2005.07.026.
28. Schreiner A, Pohlmann-Eden B, Schwartz A, Hennerici M, (1995) Epileptic seizures in subcortical vascular encephalopathy. J Neurol Sci 130: 171-177.
29. De Reuck J, Nagy E, Van Maele G, (2007) Seizures and epilepsy in patients with lacunar strokes. J Neurol Sci 263: 75-78 doi:10.1016/j.jns.2007.06.004.
30. Miki Y, Grossman RI, Udupa JK, Wei L, Kolson DL, et al. (1998) Isolated U-fiber involvement in MS: preliminary observations. Neurology 50: 1301-1306.
31. Blahak C, Baezner H, Pantoni L, Poggesi A, Chabriat H, et al. (2009) Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatr 80: 608-613 doi:10.1136/jnnp.2008.154633.
32. Viana-Baptista M, Bugalho P, Jordão C, Ferreira N, Ferreira A, et al. (2008) Cognitive function correlates with frontal white matter apparent diffusion coefficients in patients with leukoaraiosis. J Neurol 255: 360-366 doi:10.1007/s00415-008-0661-9.
33. van Harten B, Oosterman JM, Potter van Loon B-J, Scheltens P, Weinstein HC, (2007) Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 57: 70-74 doi:10.1159/000098054.
34. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, et al. (2010) Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 41: 437-442 doi:10.1161/STROKEAHA.109.563502.
35. Karatas M, (2008) Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes. Neurologist 14(6): 355-64 doi:10.1097/NRL.0b013e31817533a3.